Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR ACETIC ACID

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Acetic Acid

Subscribe to access the full database, or Sign up for a Free Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003697 ↗	Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors	Completed	University of Glasgow	Phase 1	1995-10-01	RATIONALE: Dimethylxanthenone acetic acid may stop the growth of cancer cells by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of dimethylxanthenone acetic acid in treating patients with solid tumors that have not responded to previous therapy.
NCT00044213 ↗	Trial to Assess Chelation Therapy (TACT)	Completed	National Center for Complementary and Integrative Health (NCCIH)	Phase 3	2003-09-01	The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
NCT00044213 ↗	Trial to Assess Chelation Therapy (TACT)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	2003-09-01	The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
NCT00044213 ↗	Trial to Assess Chelation Therapy (TACT)	Completed	Mt. Sinai Medical Center, Miami	Phase 3	2003-09-01	The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Acetic Acid

Condition Name

Chart
Table

Condition Name for Acetic Acid
Intervention	Trials
Unspecified Adult Solid Tumor, Protocol Specific	3
Cervical Cancer	3
Hepatic Encephalopathy	2
Skin Fibrosis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Acetic Acid
Intervention	Trials
Neoplasms	5
Uterine Cervical Neoplasms	4
Diabetes Mellitus	4
Carcinoma	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Acetic Acid

Trials by Country

Map
Table

Trials by Country for Acetic Acid
Location	Trials
United States	51
Egypt	9
Canada	8
Italy	7
United Kingdom	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Acetic Acid
Location	Trials
California	6
Texas	5
New York	4
Florida	3
New Jersey	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Acetic Acid

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Acetic Acid
Clinical Trial Phase	Trials
Phase 4	10
Phase 3	6
Phase 2/Phase 3	3
[disabled in preview]	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Acetic Acid
Clinical Trial Phase	Trials
Completed	36
Unknown status	11
Recruiting	6
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Acetic Acid

Sponsor Name

Chart
Table

Sponsor Name for Acetic Acid
Sponsor	Trials
National Cancer Institute (NCI)	7
M.D. Anderson Cancer Center	4
Digna Biotech S.L.	3
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Acetic Acid
Sponsor	Trials
Other	93
Industry	15
NIH	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Harvard Business School

Medtronic

AstraZeneca

Colorcon

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.